Institutional investors hold a majority ownership of GRFS through the 59.25% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2016, these large investors purchased a net $1.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
INSIGHT INVESTMENT MANAGEMENT (G... Bought 961.4 Thousand shares of Grifols SA
PICTET ASSET MANAGEMENT LTD. Bought 526.2 Thousand shares of Grifols SA
PUTNAM INVESTMENTS LTD. Bought 250.7 Thousand shares of Grifols SA